BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cytoo's Motility Plates to Study Cell Migration to be Launched at American Society for Cell Biology, December 15-19, 2012


12/3/2012 3:16:21 PM

Grenoble, France, 3rd -- December 2012 – CYTOO S.A., a life science systems & tools company that offers disruptive solutions for cell-based assays and High Content Screening (HCS), will launch the CYTOOplates Motility, based on CYTOO’s 2D+ Cell Culture Platform with its adhesive micropatterns, at the ASCB 2012 Annual meeting in San Francisco, USA.

After sponsoring last year’s “World Cell Race”, showcased at ASCB 2011 with huge success, CYTOO returns to ASCB 2012 to launch a new product to study cell migration for screening applications in both oncology and drug discovery.

“The objective of the first World Cell Race was to perform a large-scale comparison of cell motility across many different adherent cell types under standardized conditions. Many contestants and laboratories over the world proposed their cells as competitors, and this collaborative competition1 demonstrated how fun and serious science can be mixed”, commented Alexandra Fuchs, COO of CYTOO.

“We were delighted to participate and design a product to make this race a success. After the World Cell Race, the success of our CYTOOchips Motility was undeniable, as they provide a perfect tool for studying cell migration, showing characteristics closer to those found in vivo². We will celebrate the first anniversary of the WCR with the launch of our CYTOOplates Motility in a standard microplate format.”

CYTOOplates Motility feature adhesive tracks of 4 different widths from 2.5 to 20 µm allowing a wide range of applications including single vs collective cell migration, and cell pairing ”, explained Constantin Nelep, Sr. Product Manager of CYTOO. “We have also seen our Motility products used in other application areas, such as directional neurite outgrowth assays.”

During ASCB 2012 meeting, CYTOO will also present the company’s 2D+ Cell Culture Platform, that was launched in July. Based on the use of adhesive micropatterns to guide cell architecture and behavior in culture, this technology contrasts with traditional 2D culture where cells spread and move in an uncontrolled manner, introducing a considerable but unnoticed variability in cell function. By defining the 2D topology of cell adhesion, 2D+ Technology enables the fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations, resulting in control of cell contractility, cell polarity, organelle positioning, or cell division axis.

For more information, visit www.cytoo.com/ASCB2012

References

1. Maiuri P, Terriac E, Paul-Gilloteaux P, et al. The first World Cell Race. Curr Biol. 2012;22(17):R673–R675.

2. Sharma V, Beaty B, Patsialou A, et al. Reconstitution of in vivo macrophage-tumor cell pairing and streaming motility on one-dimensional micro-patterned substrates. IntraVital. 2012;1(1):77– 85.

About CYTOO S.A.

CYTOO S.A. is a distinctive life sciences systems & tools company that offers a disruptive solution that brings robustness, sensitivity and powerful quantification to cell-based assays and High Content Screening (HCS). The Company’s 2D+ Cell Culture Platform based on adhesive micropatterns offers control over the cells' microenvironment, leading to normalized cell morphology and behavior. The technology allows the optimization or resurrection of complex or difficult cell-based assays and opens possibilities of innovative assay development.

For more information about the complete product portfolio, visit www.cytoo.com

Contacts

CYTOO SA

cloiraud@cytoo.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES